Local inflammation caused by a monoclonal antibody that blocks the function of the rat membrane inhibitor of C3 convertase

被引:0
|
作者
Nishikawa, K
Matsuo, S
Okada, N
Morgan, BP
Okada, H
机构
[1] NAGOYA CITY UNIV,SCH MED,DEPT BIOL MOLEC,NAGOYA,AICHI 467,JAPAN
[2] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 3,NAGOYA,AICHI 466,JAPAN
[3] UNIV WALES COLL MED,DEPT BIOCHEM MED,CARDIFF CF4 4XN,S GLAM,WALES
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 156卷 / 03期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The participation of membrane inhibitors in C-mediated inflammation in vivo was analyzed in rats with the use of mAbs against membrane inhibitors of C. 512Ag inhibits C3 convertase of homologous rat C and rat CD59 prevents the formation of homologous membrane attack complexes, The histologic distributions of 512Ag and CD59 in rat skin were essentially the same, However, although intracutaneous administration of mAb against 512Ag (anti-512Ag) in the form of F(ab')(2) induced a remarkable inflammatory response, visualized by exudation of Evans blue that had been previously injected i.v., the mAb against CD59 caused no inflammatory exudate, Furthermore, anti-512Ag F(ab')(2) caused deposition of C3 followed by intense polymorphonuclear leukocyte infiltration and hemorrhage at the injection sites within 24 h, This reaction was completely abrogated by depletion of C. Therefore, spontaneous C activation on self cell membranes requires amplification at the C3 convertase step, which is restricted by membrane inhibitors such as 512Ag, thus preventing inflammation, A type II allergic response might preferentially occur at sites that exhibit an impairment of membrane inhibitor(s) of C3 convertase, However, although depletion of leukocytes by preadministration of cyclophosphamide did not reduce C3 deposition by anti-512Ag, Evans blue exudation was appreciably reduced, indicating that infiltrated leukocytes play a role in enhancing and prolonging inflammation initiated by local C activation.
引用
收藏
页码:1182 / 1188
页数:7
相关论文
共 50 条
  • [1] Monoclonal antibody against factor B that inhibits formation of the AP C3 convertase
    Subias Hidalgo, M.
    Juana Lopez, L.
    Dominguez, M.
    Rodriguez de Cordoba, S.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 287 - 288
  • [2] Novel C3 convertase gain of function in atypical haemolytic uraemic syndrome, caused by a frequent mutation in C3
    Roumenina, Lubka T.
    Frimat, Marie
    Hue, Christophe
    Chauvet, Sophie
    Bigot, Sylvain
    Satchell, Simon C.
    Mathieson, Peter W.
    Sautes-Fridman, Catherine
    Atkinson, John
    Halbwachs-Mecarelli, Lise
    Lionet, Arnaud
    Fremeaux-Bacchi, Veronique
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2201 - 2201
  • [3] A NOVEL BIFUNCTIONAL CHIMERIC COMPLEMENT INHIBITOR THAT REGULATES C3 CONVERTASE AND FORMATION OF THE MEMBRANE ATTACK COMPLEX
    FODOR, WL
    ROLLINS, SA
    GUILMETTE, ER
    SETTER, E
    SQUINTO, SP
    JOURNAL OF IMMUNOLOGY, 1995, 155 (09): : 4135 - 4138
  • [4] Stability of C3 convertase in the rat classical complement pathway
    Naito, A
    Okada, H
    MICROBIOLOGY AND IMMUNOLOGY, 1997, 41 (08) : 621 - 624
  • [5] A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function
    Roumenina, Lubka T.
    Frimat, Marie
    Miller, Elizabeth C.
    Provot, Francois
    Dragon-Durey, Marie-Agnes
    Bordereau, Pauline
    Bigot, Sylvain
    Hue, Christophe
    Satchell, Simon C.
    Mathieson, Peter W.
    Mousson, Christiane
    Noel, Christian
    Sautes-Fridman, Catherine
    Halbwachs-Mecarelli, Lise
    Atkinson, John P.
    Lionet, Arnaud
    Fremeaux-Bacchi, Veronique
    BLOOD, 2012, 119 (18) : 4182 - 4191
  • [6] CONVERSION OF C3 TO C3X IN NORMAL HUMAN SERUM - EVIDENCE FOR A MECHANISM DEPENDENT ON ANTIBODY BUT INDEPENDENT OF C3 CONVERTASE OR C3 PROACTIVATOR
    SPITZER, RE
    STITZEL, AE
    WEST, CD
    PAULING, VL
    DAVIS, NC
    FEDERATION PROCEEDINGS, 1972, 31 (02) : A740 - &
  • [7] INCORPORATION OF C3 NEPHRITIC FACTOR (C3NEF) INTO A STABILIZED C3 CONVERTASE, C3BBB(C3NEF), AND ITS RELEASE AFTER DECAY OF CONVERTASE FUNCTION
    DAHA, MR
    AUSTEN, KF
    FEARON, DT
    JOURNAL OF IMMUNOLOGY, 1977, 119 (03): : 812 - 817
  • [8] ANTIBODY INHIBITION OF NEUTROPHIL C3 RECEPTOR FUNCTION
    HAWKINS, D
    SAUVE, M
    CLINICAL RESEARCH, 1977, 25 (05): : A696 - A696
  • [9] TREATMENT OF THE C3 GAIN-OF-FUNCTION MOUSE MODEL OF AHUS THROUGH INHIBITION OF C5a, PROPERDIN OR THE C3 CONVERTASE
    Smith-Jackson, Kate
    Pappworth, Isabel Y.
    Gibson, Beth G.
    Vyas, Falguni S.
    Harris, Claire L.
    Kavanagh, David
    Kim, SungKwon
    Hourcade, Dennis E.
    Pham, Christine T. N.
    Marchbank, Kevin J.
    MOLECULAR IMMUNOLOGY, 2019, 114 : 454 - 454
  • [10] HUMAN ANTIIDIOTYPIC ANTIBODY-RESPONSES TO AUTOANTIBODY AGAINST THE ALTERNATIVE PATHWAY C3 CONVERTASE
    SPITZER, RE
    STITZEL, AE
    TSOKOS, GC
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 57 (01): : 19 - 31